Shares of Claris Lifesciences will be delisted from the BSE with effect from March 22, 2018, the pharma firm announced on Monday.

Moreover, trading in the shares will be stopped from March 15, 2018.

The company had applied for delisting of the equity shares from the exchange on February 26, 2018.

The scrip was trading 0.15 per cent down at Rs 396 at 1.35 pm (IST) on Monday against 387 points rise in Sensex around the same time. Shares of Claris Lifesciences are not listed on the National Stock Exchange (NSE).

The company in December received a letter from the promoter Athanas Enterprise Pvt Ltd to consider delisting of shares of the pharma company from the stock exchange.

Pursuant to the final delisting approval, the ‘permitted to trade’ status given to the equity shares by the Metropolitan Stock Exchange of India shall also stand withdrawn on and from the date of discontinuation of trading,” the company said in a statement.

Promoters were holding 50.13 per cent stake in the company as of December 31, 2017, whereas public held 49.87 per cent stake.